Shirley P Colyer

Title: The Contributions of Shirley P. Colyer to Oncology Research

Introduction

Shirley P. Colyer, based in Kingston, TN, is an accomplished inventor with a significant contribution to the field of oncology. Her innovative work has resulted in the development of a unique patent which aids in cancer research and understanding.

Latest Patents

Colyer holds a patent for a continuous cell-line tamarin adenocarcinoma of the colon, designated as TAC-1. This patent outlines a method for establishing an adenocarcinoma cell-line derived from the tamarin species Saquinus oedipus oedipus. The invention includes detailed steps for obtaining a sample of a colorectal tumor, along with techniques for mincing, incubating, and subculturing the sample. Additionally, the patent describes methods for the serial passage of the cell-line and details a suitable medium for its cultivation.

Career Highlights

Shirley P. Colyer is affiliated with Oak Ridge Associated Universities, where her research and innovative methodologies have sparked interest in the scientific community. Her dedication to advancing cancer research through innovative cell-line development showcases her commitment to the field.

Collaborations

Throughout her career, Colyer has collaborated with fellow researcher Lynda G. Littlefield. Their combined efforts reflect a strong partnership within the realm of medical research, enhancing the impact of their innovative projects in oncology.

Conclusion

Shirley P. Colyer's contributions to the field of oncology through her patent on a continuous cell-line for tamarin adenocarcinoma illustrate the critical role of inventors in advancing scientific knowledge. Her collaboration with researchers like Lynda G. Littlefield further emphasizes the importance of teamwork in driving innovation within medical research. Colyer's work continues to inspire future advancements in cancer treatment and research methodologies.